Cochlear implant an option for unhappy stapes patients

NewsGuard 100/100 Score

Cochlear implantation is a safe and effective treatment option for patients with far advanced otosclerosis (FAO) who have not benefitted from stapedectomy, report US researchers.

The technique should be made available as a method of aural rehabilitation for FAO patients in whom other interventions have yielded dissatisfactory results, say Maroun Semaan (University Hospitals Case, Cleveland, Ohio) and team.

The researchers carried out a retrospective chart review of 30 patients with FAO and 30 age-matched controls who had been postlingually deafened by nonotosclerotic causes, all of whom underwent cochlear implantation due to dissatisfaction with their stapedectomy.

The team found that full electrode insertion was achieved in all patients.

In addition, no facial nerve stimulation was detected at the time of surgery or at short-term (<12 months postimplantation) or long-term (>12 months postimplantation) follow up in either group.

As reported in the American Journal of Otolaryngology, radiographic findings focusing on the presence of cochlear ossification and retrofenestral otosclerosis showed these abnormalities to be present in a significantly greater proportion of the FAO group compared with the control group, at 26.4% versus 6.2%. And intraoperative cochlear ossification was found in significantly more of the FAO patients than the controls, at 29.4% versus 9.4%.

However, the presence of radiographic abnormalities did not predict hearing outcome following implantation, with all patients experiencing significant improvements more than 12 months after implantation and no significant between-group differences observed for short- and long-term postoperative word scores, sentence scores, and speech reception thresholds.

"In patients with FAO, it is rational to offer stapes surgery prior to consideration of cochlear implantation," say Semaan et al.

However, "in the event that hearing loss continues to progress or the stapedectomy fails to improve hearing, cochlear implantation should be considered for hearing rehabilitation."

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2018, August 23). Cochlear implant an option for unhappy stapes patients. News-Medical. Retrieved on April 25, 2024 from https://www.news-medical.net/news/20120925/Cochlear-implant-an-option-for-unhappy-stapes-patients.aspx.

  • MLA

    Robertson, Sally. "Cochlear implant an option for unhappy stapes patients". News-Medical. 25 April 2024. <https://www.news-medical.net/news/20120925/Cochlear-implant-an-option-for-unhappy-stapes-patients.aspx>.

  • Chicago

    Robertson, Sally. "Cochlear implant an option for unhappy stapes patients". News-Medical. https://www.news-medical.net/news/20120925/Cochlear-implant-an-option-for-unhappy-stapes-patients.aspx. (accessed April 25, 2024).

  • Harvard

    Robertson, Sally. 2018. Cochlear implant an option for unhappy stapes patients. News-Medical, viewed 25 April 2024, https://www.news-medical.net/news/20120925/Cochlear-implant-an-option-for-unhappy-stapes-patients.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Association of volatile aromatic compounds in blood with hearing impairment